Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Journal of Southern Medical University ; (12): 1015-1017, 2007.
Article Dans Chinois | WPRIM | ID: wpr-337334

Résumé

<p><b>OBJECTIVE</b>To observe the effect of selective cyclooxygenase-2 (COX-2) inhibitor on the healing of experimental gastric ulcer in rats and explore its mechanisms in light of gastric acid secretion.</p><p><b>METHODS</b>Gastric ulcers were induced in rats by an application of acetic acid to the serosal surface of the anterior gastric body. The effects of selective COX-2 inhibitor, celecoxib, on the healing of gastric ulcer, the total acidity of gastric juice, the expressions of H+, K+-ATPase mRNA and protein, and the ultrastructure of the parietal cell were observed in comparison with the effects of normal saline.</p><p><b>RESULTS</b>Nine days after ulcer induction, the ulcer area was 11.9-/+3.1 mm square and 19.7-/+3.8 mm square in rats with normal saline and celecoxib treatments, respectively (P<0.01). The total acidity of gastric juice and the expressions of H+, K+-ATPase mRNA and protein in celecoxib group were significantly higher than that in normal saline group at both 6 and 9 days after ulcer induction, but no significant difference was found between the two groups in the amount of secretary canaliculus and microvillus.</p><p><b>CONCLUSION</b>Selective COX-2 inhibitor can significantly delay the healing of experimental gastric ulcer in rats, the mechanism of which might be associated with enhanced digestive action of gastric acid on the new granulation tissue at the ulcer base as a result of celecoxib-stimulated gastric acid secretion of the parietal cells.</p>


Sujets)
Animaux , Mâle , Rats , Célécoxib , Inhibiteurs de la cyclooxygénase 2 , Pharmacologie , Utilisations thérapeutiques , Acide gastrique , Sécrétions corporelles , Régulation de l'expression des gènes codant pour des enzymes , H(+)-K(+)-Exchanging ATPase , Génétique , Métabolisme , Concentration en ions d'hydrogène , Microvillosités , Anatomopathologie , Cellules pariétales gastriques , Pyrazoles , Pharmacologie , Utilisations thérapeutiques , ARN messager , Génétique , Métabolisme , Rat Wistar , Ulcère gastrique , Traitement médicamenteux , Métabolisme , Anatomopathologie , Sulfonamides , Pharmacologie , Utilisations thérapeutiques
SÉLECTION CITATIONS
Détails de la recherche